Related Experiment Video
Updated: May 12, 2026
14:34
A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
Published on: April 3, 2026
Mapping Protein-Protein Interaction Hotspots and Unveiling a Cryptic Allosteric Pocket in PLK1 PBD via Mixed-Solvent
Sutanu Mukhopadhyay1, Suman Chakrabarty1
1Department of Chemical and Biological Sciences, S. N. Bose National Centre for Basic Sciences, Kolkata, West Bengal, India.
Summary
Researchers identified a new allosteric pocket on Polo-like kinase 1 (PLK1) Polo-box domain (PBD) using molecular dynamics. This discovery offers a promising target for developing novel cancer therapies by overcoming challenges with current PLK1 inhibitors.
Area of Science:
- Molecular Biology
- Computational Chemistry
- Drug Discovery
Background:
- Polo-like kinase 1 (PLK1) is crucial for cell division and often overexpressed in cancers.
- Targeting the PLK1 Polo-box domain (PBD) is preferred over the kinase domain to avoid off-target effects.
- Identifying druggable sites on PLK1-PBD is essential for developing effective cancer therapeutics.
Purpose of the Study:
- To systematically map protein-protein interaction (PPI) hotspots on PLK1-PBD.
- To identify novel druggable pockets on PLK1-PBD.
- To provide molecular insights for designing next-generation PLK1 inhibitors.
Main Methods:
- Mixed-solvent molecular dynamics simulations.
- Utilized amino acid and tripeptide probes to map PPI hotspots.
- Information-theoretic analysis to assess dynamic coupling.
Main Results:
- A previously uncharacterized allosteric pocket with druggability potential was discovered on PLK1-PBD.
- Tripeptide probes enhanced the opening of this allosteric pocket, suggesting utility for cryptic site identification.
- Dynamic coupling was observed between the canonical PPI interface and the novel allosteric pocket.
Conclusions:
- The identified allosteric pocket on PLK1-PBD presents a promising target for drug development.
- Molecular dynamics simulations with specific probes can reveal cryptic sites in challenging targets.
- These findings enable rational design of novel PLK1 inhibitors for cancer therapy.
